goodluck to those trying to get CHMO on the cheap.
I've got mine already, no need to waste time scalping.
Cohort 3 is already treating its first patient and still recruiting, and ASCO is just around the corner where we will likely get a more detailed look at cohort 2.
CDH-17 IND application can't be too far away.
CLTX preclinical work on melanoma trial isn't too far behind either (or may even be ahead of CDH-17).
Ann: Completion of retail component of Entitlement Offer, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $11.72K | 2.783M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2757364 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 15260220 | 25 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |